• CHEMBL179691 chembl:CHEMBL179691

    Alternate Names:

    NBI-42902

    Drug Info:

    FDA Approval not approved
    Drug Class Small molecule
    Drug Indications for treatment of postmenopausal symptoms,antineoplastic agent
    (0 More Sources)

    Publications:

  • Interaction Score: 3.86

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name GnRH receptor antagonist, NBI-42902
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • Interaction Score: 1.03

    Interaction Types & Directionality:
    antagonist (inhibitory)

    Interaction Info:
    Trial Name GnRH receptor antagonist, NBI-42902
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications for treatment of postmenopausal symptoms,antineoplastic agent
    Drug Class Small molecule
    FDA Approval not approved

    Publications:

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications: